✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
圣和化工
首页 › 产品目录 › 来那替尼

来那替尼

CAS 698387-09-6C30H29ClN6O3MW 557.0

来那替尼,CAS 登记号 698387-09-6,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于有机化学品。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。

规格参数

CAS号698387-09-6
分子式C30H29ClN6O3
分子量557.0
LogP4.9
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域有机化学品
类别有机化学品

用途与场景

有机化学品

包装与供货

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
供货周期现货/按订单安排

文件与支持

每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。

常见问题

在哪里能查到 来那替尼 的 CAS 号?

本页已列出 来那替尼 的 CAS 号:698387-09-6,可与随货 COA 核对。

可以提供哪些规格和包装?

常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。

来那替尼 一般用在什么产品里?

主要涉及有机化学品。

下单流程是怎样的?

来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。

PubChem 公开数据

Description

Neratinib · CAS 698387-09-6 · C30H29ClN6O3. UNII JJH94R3PWB.

Identification

CAS Registry Number698387-09-6
PubChem CID9915743
Molecular formulaC30H29ClN6O3
IUPAC name(E)-N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide
UNII (FDA)JJH94R3PWB

Computed Descriptors

Molecular Weight557.0
XLogP34.9
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count8
Rotatable Bond Count11
Exact Mass556.1989665
Monoisotopic Mass556.1989665
Topological Polar Surface Area112
Heavy Atom Count40
Formal Charge0

Physical description & handling notes

  • Neratinib is a tyrosine kinase inhibitor which exhibits antitumor action against Epidermal Growth Factor Receptor (EGFR), HER2, and Human Epidermal Growth Factor Receptor 4 (HER4) postive carcinomas.

Regulatory Status

GHS notification summary20% (1 / 5)

GHS Hazard Classification

GHS notification summary20% (1 / 5)
Reported hazard statementsH302 (40%), H312 (40%), H315 (40%), H319 (40%), H332 (40%), H335 (20%), H360 (40%)

This chemical does not meet GHS hazard criteria for 20% (1 of 5) of reports.

H302 (40%): Harmful if swallowed [Warning Acute toxicity, oral]

Documented Uses

  • For use as an extended adjuvant treatment in adult patients with early stage HER2-overexpressed/amplified breast cancer, to follow adjuvant trastuzumab-based therapy.
  • Neratinib is an orally available tyrosine kinase receptor inhibitor that is used in the extended adjuvant therapy of early stage breast cancer. Neratinib is associated with a low rate of transient elevations in serum aminotransferase levels during therapy, but has not been convincingly linked to cases of clinically apparent liver injury with jaundice.
  • Breast Feeding; Lactation; Antineoplastic Agents; Enzyme Inhibitors; Protein Kinase Inhibitors; Signal Transduction Inhibitors;
  • Avoid grapefruit products. Grapefruit inhibits CYP3A metabolism, which may increase the serum concentration of neratinib.
  • Exercise caution with St. John's Wort. This herb induces CYP3A metabolism and may reduce serum levels of neratinib.
  • Take at the same time every day.

Synonyms

Neratinib; 698387-09-6; HKI-272; HKI 272; JJH94R3PWB; PB-272; CHEBI:61397; CDP-820; PB 272; HKI272; DTXSID70220132; N-(4-(3-Chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide; neratinibum; RefChem:56993; DTXCID70142623; L10XE45

Frequently Asked Questions

What are the CAS number and molecular formula of Neratinib?

CAS 698387-09-6; molecular formula C30H29ClN6O3; molecular weight — g/mol.

What other names is Neratinib known by?

Neratinib, 698387-09-6, HKI-272, HKI 272, JJH94R3PWB, PB-272.

Is Neratinib classified as hazardous?

20% of GHS notifications report no hazard classification (1 of 5).

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

同类推荐

获取 来那替尼 报价

供应商:济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp
鲁ICP备19031700号-1